Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F00N4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,153
Award facts
- Contract value 100% obligated
- $10,152.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,152.90 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The DLA Troop Support Medical contract provides AmerisourceBergen Drug Corp with a flexible vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a key supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F00N4?
SPE2DR26F00N4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F00N4 worth?
The government has obligated $10,153 on SPE2DR26F00N4.
Is contract SPE2DR26F00N4 an order under another contract?
Yes. SPE2DR26F00N4 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F00N4 competed?
The extent of competition for SPE2DR26F00N4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award